Crossmark

Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)

Crossref DOI link: https://doi.org/10.1186/s40478-020-01085-3

Published Online: 2021-01-06

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bonduelle, Thomas

Hartlieb, Till

Baldassari, Sara

Sim, Nam Suk

Kim, Se Hoon

Kang, Hoon-Chul

Kobow, Katja

Coras, Roland

Chipaux, Mathilde

Dorfmüller, Georg

Adle-Biassette, Homa

Aronica, Eleonora

Lee, Jeong Ho

Blumcke, Ingmar

Baulac, Stéphanie http://orcid.org/0000-0001-6430-4693
Funding

Funding for this research was provided by:

European Research Council (682345)

Program "Investissements d'avenir" (ANR-10-IAIHU-06, ANR-18-RHUS-005)

Health Research and Development (ZonMw) and Epilepsiefonds

Suh Kyungbae Foundation

National Research Foundation of Korea (NRF) grant funded by the Korea government, Ministry of Science and ICT (2019R1A3B2066619)
License Information

Text and Data Mining valid from 2021-01-06

Version of Record valid from 2021-01-06
More Information

Article History

Received: 15 November 2020

Accepted: 18 November 2020

First Online: 6 January 2021

Availability of data and materials

: All data generated or analyzed during this study are included in this published article (and its supplementary information files).

: These studies received approval by the ethical committee CPP Ile de France II (No. ID-RCB/EUDRACT-2015-A00671-48), the Severance Hospital and KAIST Institutional Review Board and Committee on Human Research, and Amsterdam UMC (W13_85;W15_262).

: Informed consent to participate in this study were obtained from all participants (or their parent or legal guardian in the case of children).

: JH.L is a co-founder and CTO of SoVarGen, Inc., which seeks to develop new diagnostics and therapeutics for brain disorders.

Document is current

Any future updates will be listed below